A Comprehensive Review of Cannabis in Patients with Cancer: Availability in the USA, General Efficacy, and Safety

被引:0
作者
Grant Steele
Tom Arneson
Dylan Zylla
机构
[1] Frauenshuh Cancer Center,Park Nicollet Oncology Research, HealthPartners Institute
[2] Minnesota Department of Health,undefined
[3] Office of Medical Cannabis,undefined
[4] University of Minnesota,undefined
来源
Current Oncology Reports | 2019年 / 21卷
关键词
Cannabis; Marijuana; Cancer; Palliative care;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 157 条
[21]  
Lossignol D(2006)A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme Br J Cancer 95 197-679
[22]  
Burnell-Nugent M(2011)Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas—possible role of Cannabis inhalation Childs Nerv Syst 27 671-592
[23]  
Fallon MT(2013)Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation Case Rep Oncol 6 585-150
[24]  
Lynch ME(2017)A two-part safety and exploratory efficacy randomized double-blind, placebo-controlled study of a 1:1 ratio of the cannabinoids cannabidiol and delta-9-tetrahydrocannabinol (CBD:THC) plus dose-intense temozolomide in patients with recurrent glioblastoma multiforme (GBM) J Clin Oncol 35 2046-2046-1804
[25]  
Cesar-Rittenberg P(2017)Cannabidiol: state of the art and new challenges for therapeutic applications Pharmacol Ther 175 133-1709
[26]  
Hohmann AG(2007)Human cannabinoid pharmacokinetics Chem Biodivers 4 1770-1379
[27]  
Fallon MT(2017)Labeling accuracy of cannabidiol extracts sold online JAMA 318 1708-89
[28]  
Lichtman AH(2017)Chronic pain patients’ perspectives of medical cannabis Pain 158 1373-143
[29]  
Lux EA(1975)The analgesic properties of delta-9-tetrahydrocannabinol and codeine Clin Pharmacol Ther 18 84-797
[30]  
McQuade R(1975)Analgesic effect of delta-9-tetrahydrocannabinol J Clin Pharmacol 15 139-340